iShares Biotechnology ETF $IBB Shares Bought by Washington Growth Strategies LLC

Washington Growth Strategies LLC raised its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 4,996.9% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 6,524 shares of the financial services provider’s stock after purchasing an additional 6,396 shares during the period. iShares Biotechnology ETF comprises 0.6% of Washington Growth Strategies LLC’s portfolio, making the stock its 27th largest holding. Washington Growth Strategies LLC’s holdings in iShares Biotechnology ETF were worth $825,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently bought and sold shares of the stock. Ramirez Asset Management Inc. purchased a new stake in shares of iShares Biotechnology ETF in the first quarter valued at about $26,000. Financial Gravity Asset Management Inc. purchased a new stake in shares of iShares Biotechnology ETF in the first quarter valued at about $30,000. Woodside Wealth Management LLC purchased a new stake in shares of iShares Biotechnology ETF in the first quarter valued at about $31,000. CX Institutional purchased a new stake in shares of iShares Biotechnology ETF in the first quarter valued at about $32,000. Finally, Garde Capital Inc. purchased a new stake in shares of iShares Biotechnology ETF in the first quarter valued at about $36,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 0.9%

Shares of NASDAQ:IBB opened at $151.00 on Friday. The company has a 50-day simple moving average of $139.19 and a 200-day simple moving average of $130.00. iShares Biotechnology ETF has a one year low of $107.43 and a one year high of $151.62.

iShares Biotechnology ETF Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, September 19th. Stockholders of record on Tuesday, September 16th were issued a $0.0828 dividend. This represents a $0.33 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend was Tuesday, September 16th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.